PATENT CLAIM ANALYSIS

Application Number: 15865678
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "017700"]

Abstract:
The present invention provides oligopeptides, in particular, Ang-(1-7) derivatives, and methods for using and producing the same. In one particular embodiment, oligopeptides of the invention have higher blood-brain barrier penetration and/or in vivo half-life compared to the native Ang-(1-7), thereby allowing oligopeptides of the invention to be used in a wide variety of clinical applications including in treatment of cognitive dysfunction and/or traumatic brain injury.

Claim (Index 6):
The method of  claim 5 , wherein at least one of the monosacharides or disaccharides is selected from the group consisting of glucose, galactose, xylose, fucose, rhamnose, lactose, cellobiose, and melibiose.

Metadata:
- Claim Count in Document: 4.0
- Percentile: 86.0
- Lexical Diversity: 1.5
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15401944', '15134073', '15691586', '14801557', '15360698']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8356840294411257
- 35 USC 102 Novelty (BERT): 0.5556948438684886
- Combined Prediction Score: 0.807685110883862
- Mean Citation Score: 372.30146
- Max Citation Score: 444.34255999999993
- Similarity Product: 339.71393385307306

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test